Ameritas Investment Partners’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,166
| Closed | -$11.9K | – | 3290 |
|
|
2025
Q1 | $11.9K | Hold |
1,166
| – | – | ﹤0.01% | 2765 |
|
|
2024
Q4 | $16.3K | Hold |
1,166
| – | – | ﹤0.01% | 2715 |
|
|
2024
Q3 | $22.7K | Hold |
1,166
| – | – | ﹤0.01% | 2585 |
|
|
2024
Q2 | $21.7K | Buy |
+1,166
| New | +$24.6K | ﹤0.01% | 2576 |
|
|
2023
Q2 | – | Sell |
-907
| Closed | -$9.57K | – | 3175 |
|
|
2023
Q1 | $9.57K | Hold |
907
| – | – | ﹤0.01% | 2737 |
|
|
2022
Q4 | $30.5K | Hold |
907
| – | – | ﹤0.01% | 2360 |
|
|
2022
Q3 | $43K | Hold |
907
| – | – | ﹤0.01% | 2093 |
|
|
2022
Q2 | $51K | Buy |
+907
| New | +$57.2K | ﹤0.01% | 1976 |
|
|
2021
Q4 | – | Sell |
-3,305
| Closed | -$890K | – | 3113 |
|
|
2021
Q3 | $890K | Hold |
3,305
| – | – | 0.03% | 653 |
|
|
2021
Q2 | $851K | Hold |
3,305
| – | – | 0.03% | 669 |
|
|
2021
Q1 | $992K | Hold |
3,305
| – | – | 0.04% | 600 |
|
|
2020
Q4 | $843K | Sell |
3,305
-71
| -2% | -$18.3K | 0.04% | 619 |
|
|
2020
Q3 | $840K | Sell |
3,376
-57
| -2% | -$17.9K | 0.04% | 535 |
|
|
2020
Q2 | $1.19M | Buy |
3,433
+133
| +4% | +$41.5K | 0.06% | 383 |
|
|
2020
Q1 | $884K | Hold |
3,300
| – | – | 0.05% | 421 |
|
|
2019
Q4 | $1.07M | Buy |
3,300
+3,096
| +1,518% | +$898K | 0.05% | 496 |
|
|
2019
Q3 | $56K | Hold |
204
| – | – | ﹤0.01% | 1819 |
|
|
2019
Q2 | $109K | Hold |
204
| – | – | 0.01% | 1450 |
|
|
2019
Q1 | $103K | Hold |
204
| – | – | ﹤0.01% | 1457 |
|
|
2018
Q4 | $101K | Hold |
204
| – | – | 0.01% | 1372 |
|
|
2018
Q3 | $187K | Hold |
204
| – | – | 0.01% | 1124 |
|
|
2018
Q2 | $150K | Sell |
204
-871
| -81% | -$1M | 0.01% | 1261 |
|
|
2018
Q1 | $1.71M | Buy |
1,075
+229
| +27% | +$295K | 0.08% | 304 |
|
|
2017
Q4 | $758K | Sell |
846
-21
| -2% | -$12.4K | 0.03% | 640 |
|
|
2017
Q3 | $273K | Hold |
867
| – | – | 0.01% | 912 |
|
|
2017
Q2 | $254K | Buy |
867
+62
| +8% | +$17.9K | 0.01% | 930 |
|
|
2017
Q1 | $284K | Hold |
805
| – | – | 0.01% | 901 |
|
|
2016
Q4 | $148K | Buy |
805
+60
| +8% | +$12.2K | 0.01% | 1059 |
|
|
2016
Q3 | $192K | Buy |
745
+68
| +10% | +$17.5K | 0.01% | 1017 |
|
|
2016
Q2 | $144K | Hold |
677
| – | – | 0.01% | 972 |
|
|
2016
Q1 | $140K | Hold |
677
| – | – | 0.01% | 972 |
|
|
2015
Q4 | $171K | Hold |
677
| – | – | 0.01% | 947 |
|
|
2015
Q3 | $111K | Hold |
677
| – | – | 0.01% | 962 |
|
|
2015
Q2 | $127K | Sell |
677
-82
| -11% | -$14.1K | 0.01% | 999 |
|
|
2015
Q1 | $125K | Hold |
759
| – | – | 0.01% | 1043 |
|
|
2014
Q4 | $176K | Hold |
759
| – | – | 0.01% | 996 |
|
|
2014
Q3 | $137K | Hold |
759
| – | – | 0.01% | 988 |
|
|
2014
Q2 | $146K | Buy |
759
+37
| +5% | +$6.54K | 0.01% | 1021 |
|
|
2014
Q1 | $131K | Buy |
+722
| New | +$143K | 0.01% | 1003 |
|
Other funds holding NKTR
NCM
TCM
Ameritas Investment Partners's NKTR Position: Q2 2025 in Review
Ameritas Investment Partners sold out of Nektar Therapeutics (NKTR) in Q2 2025, closing a stake of 1,166 shares — an estimated $11.9K sold.
Ameritas Investment Partners first reported a position in NKTR in Q1 2014 and held it in 39 quarters. The position peaked at $1.71M in Q1 2018. 109 funds tracked by Wall St. Rank hold NKTR as of Q2 2025.
- Ameritas Investment Partners reported no remaining Nektar Therapeutics position as of Q2 2025 after selling out during the quarter.
- Ameritas Investment Partners sold 1,166 Nektar Therapeutics shares in Q2 2025, an estimated $11.9K.
- Ameritas Investment Partners first reported a position in Nektar Therapeutics in Q1 2014 and held it in 39 quarters.
- Ameritas Investment Partners's Nektar Therapeutics position peaked at $1.71M in Q1 2018.
- 109 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2025.
Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.